Vivo Capital, LLC Q4 2018 Filing
Filed February 13, 2019
Portfolio Value
$783.1B
Holdings
45
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (45 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma A/S | 2,166,832 | $135.8B | 17.34% | |
| 2 | CRNXCrinetics Pharmaceuticals Inc | 3,792,169 | $113.7B | 14.52% | |
| 3 | —Biohaven Pharmaceutical Holding Company Ltd | 1,813,340 | $67.1B | 8.56% | |
| 4 | CDXSCodexis, Inc | 2,714,458 | $45.3B | 5.79% | |
| 5 | SVASinovac Biotech Ltd. | 5,900,000 | $40.9B | 5.23% | |
| 6 | ARWRArrowhead Pharmaceuticals Inc | 2,328,475 | $28.9B | 3.69% | |
| 7 | KALVKalVista Pharmaceuticals Inc. | 1,359,149 | $26.8B | 3.43% | |
| 8 | FIXXEURHomology Medicines, Inc. | 1,159,742 | $25.9B | 3.31% | |
| 9 | —Kadmon Holdings Inc | 10,454,545 | $21.7B | 2.78% | |
| 10 | AMRSEURAmyris, Inc | 5,575,785 | $18.6B | 2.38% | |
| 11 | 1T7Tricida, Inc. | 781,185 | $18.4B | 2.35% | |
| 12 | CLDNEUREiger BioPharmaceuticals Inc | 1,791,257 | $18.2B | 2.32% | |
| 13 | —Menlo Therapeutics Inc. | 4,011,236 | $16.5B | 2.11% | |
| 14 | MEIPUSDMEI Pharma Inc | 5,778,106 | $15.3B | 1.95% | |
| 15 | IOVAIovance Biotherapeutics, Inc. | 1,600,000 | $14.2B | 1.81% | |
| 16 | VRNAVerona Pharma PLC | 1,492,951 | $13.4B | 1.72% | |
| 17 | ORTXUSDOrchard Therapeutics plc | 811,894 | $12.8B | 1.63% | |
| 18 | ACRSAclaris Therapeutics, Inc. | 1,647,214 | $12.2B | 1.55% | |
| 19 | —Obseva SA | 937,147 | $11.9B | 1.52% | |
| 20 | —Acer Therapeutics Inc | 579,051 | $11.7B | 1.49% | |
| 21 | APLSApellis Pharmaceuticals, Inc. | 874,573 | $11.5B | 1.47% | |
| 22 | MRTXEURMirati Therapeutics Inc. | 251,107 | $10.7B | 1.36% | |
| 23 | —Nabriva Therapeutics AG | 6,619,190 | $9.7B | 1.23% | |
| 24 | —Zymeworks Inc | 620,134 | $9.1B | 1.16% | |
| 25 | XENEXenon Pharmaceuticals Inc | 1,405,476 | $8.9B | 1.13% | |
| 26 | AUPHAurinia Pharmaceuticals Inc. | 1,213,290 | $8.3B | 1.06% | |
| 27 | —Soleno Therapeutics, Inc. | 4,359,683 | $7.5B | 0.95% | |
| 28 | KNSAKiniksa Pharmaceuticals | 264,878 | $7.4B | 0.95% | |
| 29 | CBAYUSDCymabay Therapeutics Inc | 906,000 | $7.1B | 0.91% | |
| 30 | GLMDGalmed Pharmaceuticals Ltd | 971,337 | $6.6B | 0.85% | |
| 31 | KALAKala Pharmaceuticals, Inc. | 1,043,020 | $5.1B | 0.65% | |
| 32 | —Zogenix, Inc. | 105,000 | $3.8B | 0.49% | |
| 33 | —Sierra Oncology, Inc | 2,438,270 | $3.2B | 0.41% | |
| 34 | ARVNArvinas Holding Co LLC | 209,666 | $2.7B | 0.34% | |
| 35 | —Genocea Biosciences Inc | 8,180,000 | $2.3B | 0.30% | |
| 36 | ZLABZai Lab Limited | 81,819 | $1.9B | 0.24% | |
| 37 | —BioPharmX Corporation | 16,128,515 | $1.7B | 0.22% | |
| 38 | —DBV Technologies S.A. | 269,995 | $1.7B | 0.22% | |
| 39 | SELBUSDSelecta Biosciences Inc | 546,054 | $1.5B | 0.19% | |
| 40 | —Agile Therapeutics, Inc. | 1,513,975 | $872.0M | 0.11% | |
| 41 | —Trevena, Inc. | 1,728,000 | $743.0M | 0.09% | |
| 42 | —Foamix Pharmaceuticals Ltd. | 201,478 | $723.0M | 0.09% | |
| 43 | —Akari Therapeutics Plc | 345,850 | $543.0M | 0.07% | |
| 44 | —Sunesis Pharmaceuticals, Inc. | 195,474 | $81.0M | 0.01% | |
| 45 | —Soleno Therapeutics, Inc. | 188,772 | $19.0M | 0.00% |